SE8602931L - Komposition med reglerad frigoring - Google Patents

Komposition med reglerad frigoring

Info

Publication number
SE8602931L
SE8602931L SE8602931A SE8602931A SE8602931L SE 8602931 L SE8602931 L SE 8602931L SE 8602931 A SE8602931 A SE 8602931A SE 8602931 A SE8602931 A SE 8602931A SE 8602931 L SE8602931 L SE 8602931L
Authority
SE
Sweden
Prior art keywords
phase
active material
biologically active
composition
monoglyceride
Prior art date
Application number
SE8602931A
Other languages
Unknown language ( )
English (en)
Other versions
SE8602931D0 (sv
SE457693B (sv
Inventor
S Engstrom
K Larsson
B Lindman
Original Assignee
Drilletten Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drilletten Ab filed Critical Drilletten Ab
Priority to SE8602931A priority Critical patent/SE457693B/sv
Publication of SE8602931D0 publication Critical patent/SE8602931D0/sv
Priority to CA000538239A priority patent/CA1296631C/en
Priority to JP62504060A priority patent/JPH0759523B2/ja
Priority to EP19870904411 priority patent/EP0314689B1/en
Priority to AT87904411T priority patent/ATE74277T1/de
Priority to DE87904411T priority patent/DE3778024D1/de
Priority to PCT/SE1987/000279 priority patent/WO1988000059A1/en
Publication of SE8602931L publication Critical patent/SE8602931L/sv
Priority to NO880560A priority patent/NO175454C/no
Priority to DK105888A priority patent/DK105888A/da
Priority to FI886055A priority patent/FI97687C/sv
Publication of SE457693B publication Critical patent/SE457693B/sv
Priority to US08/107,908 priority patent/US5371109A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8602931A 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas SE457693B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
CA000538239A CA1296631C (en) 1986-07-01 1987-05-28 Controlled-release composition
PCT/SE1987/000279 WO1988000059A1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
AT87904411T ATE74277T1 (de) 1986-07-01 1987-06-12 Zubereitung eines in einer l2-phase geloesten oder dispergierten biologischen aktiven materials mit geregelter verabreichung.
EP19870904411 EP0314689B1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
JP62504060A JPH0759523B2 (ja) 1986-07-01 1987-06-12 調節放出組成物
DE87904411T DE3778024D1 (sv) 1986-07-01 1987-06-12
NO880560A NO175454C (no) 1986-07-01 1988-02-09 Fremgangsmåte for fremstilling av et preparat som har form av en L2-fase
DK105888A DK105888A (da) 1986-07-01 1988-02-29 Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel
FI886055A FI97687C (sv) 1986-07-01 1988-12-30 Komposition för kontrollerad utlösning av ett biologiskt aktivt material löst eller dispergerat i en L2-fas
US08/107,908 US5371109A (en) 1986-07-01 1993-08-18 Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Publications (3)

Publication Number Publication Date
SE8602931D0 SE8602931D0 (sv) 1986-07-01
SE8602931L true SE8602931L (sv) 1988-01-02
SE457693B SE457693B (sv) 1989-01-23

Family

ID=20364989

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Country Status (8)

Country Link
EP (1) EP0314689B1 (sv)
JP (1) JPH0759523B2 (sv)
CA (1) CA1296631C (sv)
DE (1) DE3778024D1 (sv)
DK (1) DK105888A (sv)
FI (1) FI97687C (sv)
SE (1) SE457693B (sv)
WO (1) WO1988000059A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
EP0429419B1 (en) * 1989-10-20 1996-02-14 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
DK0789580T3 (da) 1994-11-03 2002-09-09 Novartis Ag Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
EP0988046B1 (en) 1997-01-30 2004-09-15 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin a
DK0942780T3 (da) * 1997-09-09 2003-10-27 Lyotropic Therapeutics Inc Overtrukne partikler, fremgangsmåder til fremstilling deraf og anvendelse deraf
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY
CN114145290A (zh) * 2021-06-02 2022-03-08 贵州省烟草科学研究院 高效长效昆虫性诱芯及其制作方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
FI886055A (sv) 1988-12-30
FI97687B (sv) 1996-10-31
DE3778024D1 (sv) 1992-05-07
SE8602931D0 (sv) 1986-07-01
DK105888D0 (da) 1988-02-29
JPH01503140A (ja) 1989-10-26
SE457693B (sv) 1989-01-23
EP0314689B1 (en) 1992-04-01
FI97687C (sv) 1997-02-10
CA1296631C (en) 1992-03-03
JPH0759523B2 (ja) 1995-06-28
EP0314689A1 (en) 1989-05-10
WO1988000059A1 (en) 1988-01-14
DK105888A (da) 1988-02-29

Similar Documents

Publication Publication Date Title
SE8602931L (sv) Komposition med reglerad frigoring
Nicolaides et al. The skin surface lipids of man compared with those of eighteen species of animals
FI964959A (sv) Lipidbaserad sammansättning innehållande diacylglycerol, fosfolipid, plas vätska och biologiskt aktivt material
KR910000655B1 (ko) 신규 형태의 연질캡슐 제조방법
JPS5777626A (en) Palatable composition containing oil or oily substance
SE8206744D0 (sv) Preparat for kontrollerad avgivning av substanser
SE8305316D0 (sv) Topiskt applicerbart preparat
ES2013724B3 (es) Micro-capsulas.
FI61123C (fi) Foerfarande foer framstaellning av en fettprodukt som laempar sig foer framstaellning av avkortningsmedel och emulgerade livsmedelspastor
DK287186D0 (da) Fremgangsmaade til fremstilling af fiskefoder
Ando et al. Antitumor activity of glyceryl ethers
FR2584925B1 (fr) Composition de corps gras d'origine vegetale pour usage cosmetique
JPS5517328A (en) Insulin-containing emulsion and its preparation
JPS5759628A (en) Solubilizing method
GB2150588A (en) Shampoo for promoting growth of hair
JPS54110210A (en) Preparation of oil for meat-roasting hot plate
JPS5759627A (en) Solubilization
JPS57212243A (en) Preventing method for formation of nitrosamine in rubber
JPS5564755A (en) Shortening for "baumkuchen" (germany cake)
JPS55165751A (en) Creamy composition
JPS53145927A (en) Emulsion for hair treatment
ES8404849A1 (es) Metodo para la preparacion de composiciones farmaceuticas conteniendo sulfadiazina de plata como sustancia activa.
JPS5550867A (en) Improvement in color of fried food
ES2008097B3 (es) - 2-sustitutivo 4, 4, 7, 7-tetrametil-1,3dioxacicloheptano, su fabricacion y utilizacion como sustancia aromatica
JPS5574750A (en) Preparation of flowing shortening

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8602931-1

Effective date: 19940210

Format of ref document f/p: F